PARP1 and neoplasm: Besides, a negative feedback mechanism that prevents excessive depletion of NAD+ by PARP1 upon DNA damage has been observed – decreased NAD+ levels promoted the binding of PARP1 to DBC1 (deleted in breast cancer 1), a potential tumor suppressor, which inhibits PARP1 activity and leads to DNA damage accumulation (103).